P1122 COMPARISONS OF POPULATIONS IN FALDAPREVIR PHASE III STUDIES BASED ON PEGYLATED INTERFERON a-2a AND RIBAVIRIN-PREDICTED RESPONSIVENESS AND IMPACT ON ACHIEVING SVR12.

Authors :: Ferenci, P.
Jensen, D.M.
Dieterich, D.
Jacobson, I.M.
Romero-Gómez, M.
Foster, G.R.
Asselah, T.
Cooper, C.
Tural, C.
Streinu-Cercel, A.
Ryder, S.
Puoti, M.
Tam, E.
Calleja, J.L.
Núñez, M.
Quinson, A.-M.
Böcher, W.
Voss, F.
Scherer, J.
Source :: Journal of Hepatology. Apr2014 Supplement, Vol. 60, pS453-S453. 1p.
Publication Year :: 2014

Subjects :: *THERAPEUTIC use of interferons
*RIBAVIRIN
*POPULATION health
*HEPATITIS C
*HEPATITIS C treatment
*GENOTYPES
*PATIENTS

Full Text Access

Tools